Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | THPO | P40225 | 1/20 | 0.33 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.33 |
| ▸ | LCK | P06239 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL203518 | 0.77 | ALDH1A1 (0.44) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL28195911 | 0.76 | ALDH1A1 (0.43) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL6552222 | 0.74 | — | — | |
| SCHEMBL20680488 | 0.74 | ALDH1A1 (0.41) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL204297 | 0.74 | ALDH1A1 (0.41) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL339422 | 0.74 | — | — | |
| SCHEMBL2767718 | 0.74 | ALDH1A1 (0.41) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| SCHEMBL27554009 | 0.72 | ALDH1A1 (0.39) | ALDH1A1TSHRLMNAHSD17B10TDP1 | |
| Methyl Alcohol SCHEMBL3363304 | 0.72 | — | — | |
| SCHEMBL7122275 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3663301-B1 | BORON-CONTAINING COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE DEPOSITION OF BORON CONTAINING FILMS | VERSUM MAT US LLC (US) | 2023-08-30 | — | — | EP | claimed |
| CN-117059479-A | Pattern forming method, pattern and semiconductor device | 成都高真科技有限公司 | 2023-11-14 | — | — | CN | disclosed |
| EP-3663301-B1 | BORON-CONTAINING COMPOUNDS, COMPOSITIONS, AND METHODS FOR THE DEPOSITION OF BORON CONTAINING FILMS | VERSUM MAT US LLC (US) | 2023-08-30 | — | — | EP | disclosed |
| CN-116411261-A | Boron-containing compounds, compositions, and methods for depositing boron-containing films | 弗萨姆材料美国有限责任公司 | 2023-07-11 | — | — | CN | disclosed |
| US-11605535-B2 | Boron-containing compounds, compositions, and methods for the deposition of a boron containing films | VERSUM MATERIALS US, LLC (US) | 2023-03-14 | — | — | US | disclosed |
| EP-2199428-B1 | Method for removal of carbon from an organosilicate material | VERSUM MAT US LLC (US) | 2018-01-24 | — | — | EP | disclosed |
| EP-2261390-A2 | Mechanical enhancer additives for low dielectric films | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2010-12-15 | — | — | EP | disclosed |
| US-20100151206-A1 | Method for Removal of Carbon From An Organosilicate Material | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2010-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11605535-B2 | Boron-containing compounds, compositions, and methods for the deposition of a boron containing films | CD79B, BCL6B, BCL6 | ALDH1A1 3534/4885TSHR 4628/4885LMNA 242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.